ArticleFrontiers in oncology2022

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.

Ryota Tashiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.